{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:39:34Z","timestamp":1792492774441,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.msard.2026.107972","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:03:48Z","timestamp":1791821028000},"page":"107972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum and plasma leptin levels in patients with Multiple Sclerosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"116","author":[{"given":"Kiana","family":"Darfarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Hajizadehanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6950-9223","authenticated-orcid":false,"given":"Sadra Samadi","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Arab","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadReza","family":"Toghyani DolatAbadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Hasanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehra","family":"Fekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0991-7752","authenticated-orcid":false,"given":"Rasoul","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0024","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC. Med. Res. Methodol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107972_bib0016","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0165-5728(03)00154-1","article-title":"Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta","volume":"139","author":"Batocchi","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0023","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res. Synth. Methods"},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/biomedicines10020335","article-title":"Regulatory cells in multiple sclerosis: from blood to brain","volume":"10","author":"Calahorra","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.msard.2026.107972_bib0026","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.metabol.2015.05.001","article-title":"Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate","volume":"64","author":"Carrieri","year":"2015","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0027","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaut.2004.05.007","article-title":"Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients","volume":"23","author":"Chatzantoni","year":"2004","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0049","first-page":"115","article-title":"Leptin enhances the release of cytokines by peripheral blood mononuclear cells from acute multiple sclerosis patients","volume":"22","author":"Chen","year":"2006","journal-title":"Neurosci. Bull."},{"issue":"37","key":"10.1016\/j.msard.2026.107972_bib0028","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027247","article-title":"Investigation of blood leptin and adropin levels in patients with multiple sclerosis: a CONSORT-clinical study","volume":"100","author":"Cinkir","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.msard.2026.107972_bib0022","doi-asserted-by":"crossref","unstructured":"J. Cohen Statistical power analysis for the behavioral sciences: routledge; 2013.","DOI":"10.4324\/9780203771587"},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0012","first-page":"68","article-title":"Role of leptin in autoimmune diseases","volume":"8","author":"Cojocaru","year":"2013","journal-title":"Maedica"},{"key":"10.1016\/j.msard.2026.107972_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101409","article-title":"Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait","volume":"36","author":"Dashti","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0047","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2007.01.011","article-title":"A key role of leptin in the control of regulatory T cell proliferation","volume":"26","author":"De Rosa","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.msard.2026.107972_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105559","article-title":"Peripheral blood age-sensitive immune markers in multiple sclerosis: relation to sex, cytomegalovirus status, and treatment","volume":"112","author":"Desu","year":"2025","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0031","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/08820139.2018.1528270","article-title":"Adipokines in multiple sclerosis patients with and without optic neuritis as the first clinical presentation","volume":"48","author":"D\u00fczel","year":"2019","journal-title":"Immunol. Invest."},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0015","first-page":"60","article-title":"The relation between peptide hormones and sex hormone in patients with multiple sclerosis","volume":"12","author":"Eftekhari","year":"2013","journal-title":"Iran. J. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107972_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076555","article-title":"Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease","volume":"8","author":"Emamgholipour","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107972_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/486282","article-title":"Serum leptin levels in treatment-naive patients with clinically isolated syndrome or relapsing-remitting multiple sclerosis","volume":"2014","author":"Evangelopoulos","year":"2014","journal-title":"Autoimmune Dis."},{"issue":"4","key":"10.1016\/j.msard.2026.107972_bib0033","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/08820139.2016.1157811","article-title":"Polymorphism in leptin and leptin receptor genes may modify leptin levels and represent risk factors for multiple sclerosis","volume":"45","author":"Farrokhi","year":"2016","journal-title":"Immunol. Invest."},{"issue":"3","key":"10.1016\/j.msard.2026.107972_bib0048","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/B:JOCI.0000025450.48267.a5","article-title":"Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients","volume":"24","author":"Frisullo","year":"2004","journal-title":"J. Clin. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107972_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jneuroim.2007.08.008","article-title":"The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis","volume":"192","author":"Frisullo","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0034","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/s41598-023-30237-3","article-title":"UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing-remitting type of multiple sclerosis","volume":"13","author":"G\u00f3rska","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107972_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211007687","article-title":"Inflammation in multiple sclerosis","volume":"14","author":"Haase","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1468-1331.2009.02701.x","article-title":"Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study","volume":"17","author":"Hietaharju","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2026.107972_bib0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.msard.2015.10.002","article-title":"Identifying clues to molecular etiology of multiple sclerosis in South Indian patients","volume":"5","author":"Joseph","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107972_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101384","article-title":"Adipokines are associated with pediatric multiple sclerosis risk and course","volume":"36","author":"Keyhanian","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107972_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577090","article-title":"Expression of LEP, LEPR and PGC1A genes is altered in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis","volume":"338","author":"Koli\u0107","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0038","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5114\/ninp.2012.27211","article-title":"Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis","volume":"46","author":"Kraszula","year":"2012","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.msard.2026.107972_bib0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/B978-0-444-52001-2.00002-9","article-title":"Pathology of multiple sclerosis and related inflammatory demyelinating diseases","volume":"122","author":"Kutzelnigg","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107972_bib0009","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107972_bib0055","doi-asserted-by":"crossref","DOI":"10.1186\/s40608-014-0033-1","article-title":"Altered NK cell function in obese healthy humans","volume":"2","author":"Laue","year":"2015","journal-title":"BMC. Obes."},{"issue":"5","key":"10.1016\/j.msard.2026.107972_bib0052","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.msard.2026.107972_bib0045","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s00415-022-11519-8","article-title":"Adipokines in multiple sclerosis patients are related to clinical and radiological measures","volume":"270","author":"Loonstra","year":"2023","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0046","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/acn3.51291","article-title":"Obesity and the risk of Multiple sclerosis. The role of leptin","volume":"8","author":"Marrodan","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/oby.2002.3","article-title":"Leptin's sexual dimorphism results from genotype by sex interactions mediated by testosterone","volume":"10","author":"Martin","year":"2002","journal-title":"Obes. Res."},{"issue":"14","key":"10.1016\/j.msard.2026.107972_bib0051","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1073\/pnas.0408995102","article-title":"Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells","volume":"102","author":"Matarese","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1471-4159.2006.04232.x","article-title":"Multiple sclerosis: a battle between destruction and repair","volume":"100","author":"McQualter","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2026.107972_bib0039","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2377-13-172","article-title":"Increased leptin and A-FABP levels in relapsing and progressive forms of MS","volume":"13","author":"Messina","year":"2013","journal-title":"BMC. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0025","first-page":"1","article-title":"The jackknife-a review","volume":"61","author":"Miller","year":"1974","journal-title":"Biometrika"},{"key":"10.1016\/j.msard.2026.107972_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.603710","article-title":"Autophagy in multiple sclerosis: two sides of the same coin","volume":"14","author":"Misrielal","year":"2020","journal-title":"Front. Cell Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24170","article-title":"Investigation of serum levels of orexin-A, transforming growth factor \u03b2, and leptin in patients with multiple sclerosis","volume":"36","author":"Moharami","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"5","key":"10.1016\/j.msard.2026.107972_bib0043","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","article-title":"Immunologic effects of Metformin and Pioglitazone treatment on metabolic syndrome and multiple sclerosis","volume":"73","author":"Negrotto","year":"2016","journal-title":"JAMa Neurol."},{"issue":"8","key":"10.1016\/j.msard.2026.107972_bib0041","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/1352458509106515","article-title":"Serum leptin levels during pregnancy in multiple sclerosis","volume":"15","author":"Neuteboom","year":"2009","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.msard.2026.107972_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7191080","article-title":"Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development","volume":"2020","author":"Pegoretti","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"issue":"4","key":"10.1016\/j.msard.2026.107972_bib0042","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11011-015-9665-1","article-title":"Hyperinsulinemia in newly diagnosed patients with multiple sclerosis","volume":"30","author":"Penesova","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.msard.2026.107972_bib0019","unstructured":"Rayyan [Available from: https:\/\/www.rayyan.ai\/."},{"issue":"19","key":"10.1016\/j.msard.2026.107972_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910845","article-title":"Adipokines as immune cell modulators in multiple sclerosis","volume":"22","author":"Rijnsburger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.msard.2026.107972_bib0013","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000353567","article-title":"Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion","volume":"20","author":"Rotondi","year":"2013","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4049\/jimmunol.1301158","article-title":"Leptin metabolically licenses T cells for activation to link nutrition and immunity","volume":"192","author":"Saucillo","year":"2014","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2026.107972_bib0053","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/JLB.3AB0820-092RR","article-title":"Peripheral leptin signaling persists in innate immune cells during diet-induced obesity","volume":"109","author":"Souza-Almeida","year":"2021","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.msard.2026.107972_bib0006","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/oxfordjournals.jbchem.a124914","article-title":"Enhancement of gamma-actin protein during liver regeneration: its accumulation in a region adjacent to the hepatocyte plasma membrane","volume":"118","author":"Tanahashi","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.msard.2026.107972_bib0020","unstructured":"WebPlotDigitizer [Available from: https:\/\/apps.automeris.io\/wpd4\/."},{"issue":"8","key":"10.1016\/j.msard.2026.107972_bib0021","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107972_bib0054","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1152\/ajpendo.00057.2011","article-title":"Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions","volume":"302","author":"Wrann","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1111","key":"10.1016\/j.msard.2026.107972_bib0017","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/postgradmedj-2017-135397","article-title":"Association between circulating leptin levels and multiple sclerosis: a systematic review and meta-analysis","volume":"94","author":"Xie","year":"2018","journal-title":"Postgrad. Med. J."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:54:01Z","timestamp":1792490041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826010072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":55,"alternative-id":["S2211034826010072"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107972","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum and plasma leptin levels in patients with Multiple Sclerosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107972"}}